Common treatments for hyperprolactinemia

Hyperprolactinemia is the most common pituitary disease, which is characterized by galactorrhea and hypogonadism. Female patients may have decreased libido and loss of sexual desire, which will be relieved after treatment as PRL levels decrease. Male patients mainly show decreased libido and impotence. In severe cases, body hair loss, testicular atrophy, decreased sperm count and even azoospermia may occur. It is a very serious disease, so what are the common treatments for hyperprolactinemia? Below, we will introduce the common treatments for hyperprolactinemia.

Treatment of hyperprolactinemia 1. Treatment of the primary disease

For example, eliminate adverse mental stimulation, stop taking HPRL-inducing drugs, and actively treat primary diseases such as pituitary tumors, hypothyroidism, Cushing's disease, etc.

Treatment of hyperprolactinemia 2. Ovulation induction therapy

It is suitable for patients with HPRL, anovulatory infertility, and those who cannot successfully ovulate and become pregnant after simple bromocriptine treatment. Comprehensive therapy can save antiprolactin, shorten the treatment cycle, and increase the ovulation rate and pregnancy rate. It is a common treatment measure for hyperprolactinemia.

Treatment of hyperprolactinemia 3. Surgical treatment

It is suitable for patients with giant adenoma and compression symptoms, as well as patients with drug-resistant tumors, patients who are ineffective in bromocriptine treatment, and patients with multiple pituitary hormone secretion in serotype-deficient cells. The current transsphenoidal microsurgery is safe, convenient, and easy to perform, and its efficacy is similar to that of bromocriptine therapy.

The above-mentioned treatment methods for hyperprolactinemia are proven to be effective in practice. After mastering the treatment methods for hyperprolactinemia, everyone is required to actively go to a regular hospital to treat this disease in order to restore their health to the greatest extent possible.